Michael Gathright, the Chief Customer Officer of Healthequity, Inc., has reported the acquisition of 662 shares of common stock in a recent SEC filing. This transaction, which took place on October 6, 2026, indicates Gathright's confidence in the company's future performance and aligns his interests with those of shareholders.
Healthequity, Inc. operates in the business services sector, specifically categorized under services-business services, NEC. The company, which trades under the symbol HQY, is based in Draper, Utah. This filing, accession number 0002076763-26-000011, was made on October 8, 2026.
According to the filing, Gathright acquired the shares at a price of $91.1553 each, bringing his total ownership to 39,231 shares following the transaction. The filing states, "transaction code F" indicating a direct acquisition of shares.
This acquisition may influence other executives within the business services industry, as it reflects a trend of aligning personal investments with company performance. Such insider transactions can signal confidence in a company's trajectory, potentially affecting market perceptions and actions by competitors.
The filing does not say what happens next.
In the filing, Gathright's transaction is categorized under the SEC Form 4, which is used to report changes in the ownership of securities by corporate insiders. This specific transaction reflects Gathright's direct ownership of the shares, as indicated by the ownership nature code 'D'.
Healthequity, Inc. is incorporated in Delaware and operates on a fiscal year that ends on January 31. The company's business address is listed as 15 West Scenic Pointe Drive, Suite 100, Draper, Utah, with a business phone number of 801-727-1000.
The filing also confirms that Gathright is not a director or a ten percent owner of the company, but holds the position of Chief Customer Officer, further emphasizing his role and responsibilities within the organization.
While the filing provides detailed information regarding the transaction, it does not include any insights into Gathright's future plans or the potential impact of this acquisition on his role at Healthequity, Inc.